Individuals who are suffering from Multiple Sclerosis might have a certain antibody inside their blood, perhaps permitting for early discovery with a blood test prior to any symptoms showing up. There is a potassium protein that contained the antibodies in question and they were found in over six of nearly 20 test subjects who did not have any MS symptoms during the time of testing. Yet each had ended up developing the disease by nine months after the test. Two other participants of the group ended up showing borderline existence of the antibodies.
The results of the entire group were measured against a control group of nearly 15 other people who were the same sex and age as the original group. These people did not have any of the unusual antibodies in their blood and none of them went on to develop MS. This test was held by a technical university located in Germany. The researchers plan on showing their findings at the American Academy of Neurology’s yearly meeting, which is set to be held in April.
Such findings are very positive for the sufferers of MS, as information might help lead to early exposure and also to possible positive treatment. Eventually there may even be prevention of Multiple Sclerosis. The research study’s leader, Dr. Viola Biberacher, stated that if such results could be repeated in bigger parts of the population, then the findings could possibly aid in finding MS earlier in patients. By discovering the disease before symptoms start to show up could mean that physicians and scientists might possibly be able to prepare and treat and maybe even stop some of the symptoms of MS.
These discoveries have also shown that antibodies that have developed in a protein known as KIR4.1, which has been discovered in several individuals with MS, came before the onset of the disease. This suggests a part of the auto antibody in the way of how MS might develop, Biberacher added.
Since the year 2008, Multiple Sclerosis diagnosis rates have risen almost 12 percent worldwide. There are over two million people that are believed to be suffering from the incapacitating condition at this time. Presently there is not any sort of cure for MS either. It is an autoimmune disease which affects the insulating shields inside the cells of nerves throughout the spinal cord and brain.
It is believed that MS develops as the result of a genetic disposition, along with other exterior factors, such as having a deficiency of sun exposure. That seems to aid in the diseases advancement. Countries located in the northern part of the world, that have less sunlight seem to have a higher frequency of Multiple Sclerosis, with Canada having about 290 assessed cases for every 100,000 amount of their population. Sweden also has high rates of MS, with an estimated 190 cases for about every 100,000 individuals. But unlike these countries, doctors located in the United States are not obligated to report occurrences of the condition to the Centers for Disease Control. So the amount of official cases in America stays uncertain.
Biberacher is hopeful about treatments in the future. She stated that the next step of the process was to authorize findings in bigger groups and figure out just how many years there is before Multiple Sclerosis begins that the antibody response begins to start developing in the body. If the individuals who are suffering from Multiple Sclerosis do have such an antibody inside their blood, perhaps permitting for early discovery prior to any symptoms showing up will be available to them in the future.
By Kimberly Ruble